Drug Patent Watch

JULY 25, 2024

The generic drug market has been significantly impacted by the COVID-19 pandemic, with both challenges and opportunities arising from the crisis. As the world continues to recover…

Marketing 98

Marketing Drugs 98

Drug Discovery World

MAY 7, 2024

What you will learn: Where is the opportunity in the mAb market and where is the market heading? What effect has antibody engineering had on drug discovery and development? What are the main drivers and challenges for the market in the next ten years? The post Where is the opportunity in the therapeutic antibody market?

Marketing 130

Marketing Engineering Therapies Drugs 130

Drug Discovery World

APRIL 8, 2024

What you will learn: Where is the opportunity in the mAb market and where is the market heading? What effect has antibody engineering had on drug discovery and development? What are the main drivers and challenges for the market in the next ten years? The post Where is the opportunity in the therapeutic antibody market?

Marketing 148

Marketing Engineering Therapies Research 148

Drug Discovery World

FEBRUARY 22, 2024

market capitalisation growth to $3.67 The top 20 global biopharmaceutical companies experienced varied year-on-year (YoY) market capitalisation shifts in 2023 amid the macroeconomic headwinds, steep patent cliffs and the commencement of US drug price negotiations under the Inflation Reduction Act (IRA). billion for 2023.

Marketing 130

Marketing FDA Approval Biosimilars FDA 130

Drug Discovery World

JUNE 1, 2023

Sales of branded anti-obesity drugs (AOB) could hit $44 billion in 2030 vs $2.5 Pipeline developments such as oral GLP-1s by Lilly and Pfizer, and Amgen and Lilly’s dual- and triple-combination drugs represent upside to our view.” Bloomberg Intelligence’s model only includes approved drugs and those in ongoing Phase III trials.

Marketing 130

Marketing Drugs Therapies Trials 130

Drug Discovery World

MAY 20, 2024

Glucagon-like peptide-1 (GLP-1) receptor agonist sales for the type 2 diabetes and obesity markets are forecast to reach over $125 billion in the seven major markets (7MM) by 2033, according to analysts GlobalData. But there is an opportunity for new players to join the race, as the market is vast.

Marketing 130

Marketing Doctors Clinical Development Therapies 130

Drug Discovery World

APRIL 15, 2024

Join DDW for this free event ‘ Where is the opportunity in the therapeutic antibody market? ’, which is co-sponsored by Bio-Rad and Benchling. What you will learn: Where is the opportunity in the monoclonal antibody market and where is the market heading? Register for free now to secure your place.

Marketing 130

Marketing Engineering Therapies Disease 130

Drug Discovery World

APRIL 8, 2024

Join DDW for this free event ‘ Where is the opportunity in the therapeutic antibody market? ’, which is co-sponsored by Bio-Rad and Benchling. What you will learn: Where is the opportunity in the monoclonal antibody market and where is the market heading? The post Where is the opportunity in the therapeutic antibody market?

Marketing 130

Marketing Engineering Therapies Disease 130

Drug Discovery World

APRIL 29, 2024

Join DDW for this free event ‘ Where is the opportunity in the therapeutic antibody market? ’, which is co-sponsored by Bio-Rad and Benchling. What you will learn: Where is the opportunity in the monoclonal antibody market and where is the market heading? Register for free now to secure your place.

Marketing 130

Marketing Engineering Therapies Disease 130

Drug Discovery World

OCTOBER 20, 2023

The post Free clinical trial health check to bring drugs to market faster appeared first on Drug Discovery World (DDW).

Clinical Trials 163

Clinical Trials Trials Marketing Drugs 163

Drug Discovery World

FEBRUARY 5, 2024

Hosted by DDW and sponsored by Astrea Biosciences “Cell and gene therapies – how can market growth be sustained to maximise on opportunities” – will be free to attend on 28 February at 7AM PST / 10AM EST / 3PM GMT / 4PM CET. Join this free webinar and learn about some of the key opportunities that are available to drug discovery and development (..)

Therapies 130

Therapies Marketing RNA Science 130

Drug Discovery World

JANUARY 4, 2023

Increasing collaborations and partnerships between market players are expected to contribute to significant growth in the antibodies market between 2022 and 2030, ResearchAndMarkets.com predicts. The post Partnerships and collaborations fuel antibodies market growth appeared first on Drug Discovery World (DDW).

Marketing 130

Marketing Drugs 130

Drug Discovery World

APRIL 18, 2023

Sascha Fischer, Business Development Manager for Automation at Genedata looks at three critical digitalisation components that streamline the journey to market. Username or E-mail Password Remember Me Forgot Password The post Accelerating time to market through digitalisation appeared first on Drug Discovery World (DDW).

Marketing 130

Marketing Drugs 130

Drugs.com

APRIL 4, 2024

THURSDAY, April 4, 2024 (HealthDayNews) -- Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio.

Marketing 111

Marketing Drugs Pharmaceuticals Trials 111

Drug Discovery World

FEBRUARY 28, 2023

A new strategic guide , intended to help manufacturers bring rare disease products to market, has been launched to mark Rare Disease Day (February 28). Craig Caceci, Terebellum’s Managing Director, commented: “Bringing any product to market, particularly those used to treat rare and orphan diseases is a challenge enough.

Marketing 130

Marketing Disease Production Treatment 130

Cytel

MAY 7, 2024

Here we explore the evolution and impact of market exclusivity policies in the EU and US, highlighting their role in fostering innovation and accessibility in rare disease treatment. Market exclusivity for orphan drugs traces back to the early 1980s in the United States, with the landmark Orphan Drug Act of 1983.

Marketing 59

Marketing Production Drugs Disease 59

Drug Discovery World

OCTOBER 4, 2023

Our focus in the near term is on the registration, approval and commercialization of Kinselby in the European Union, Switzerland and the UK and we are on track to file for European Marketing Approval of Kinselby in Q1 2024, to rapidly bring this therapy into clinical use. 4SC is

Marketing 130

Marketing Treatment Therapies Disease 130

Drug Discovery World

SEPTEMBER 28, 2023

Both GTPs and GMPs must be followed to get cell-based advanced therapies or tissue-based therapy products to market. How will not having a GMP supplier impact the speed a therapy gets to market? The post Webinar: Avoid unnecessary delays getting cell therapies to market appeared first on Drug Discovery World (DDW).

Therapies 130

Therapies Marketing Clinical Development Production 130

Drug Discovery World

FEBRUARY 13, 2024

In this webinar, hosted by DDW and sponsored by Astrea Bioseparations, you will learn about how market growth can be sustained to maximise on opportunities in cell and gene therapy (CGT). The post Cell & gene therapies: How can market growth be sustained to maximise on opportunities?

Therapies 130

Therapies Marketing RNA Science 130

Drugs.com

MARCH 11, 2024

MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a.

Marketing 115

Marketing Trials Pharmaceuticals Drugs 115

Drug Discovery World

OCTOBER 17, 2023

Andreas Dreps DDW is delighted to confirm that ICON’s SrVP and Global Head of Science Andreas Dreps and Senior Director Muaiad Kittaneh will present a session on identifying research strategies to get to market faster. The post DDW Cancer Research Summit: Strategies to get to market faster appeared first on Drug Discovery World (DDW).

Marketing 130

Marketing Research Clinical Trials Science 130

ProRelix Research

NOVEMBER 2, 2023

Although clinical trials provide useful information regarding the efficacy and safety of new drugs, biological products, and medical devices, the information captured through them is not all-encompassing. Limited patient populations, […] The post Post-Marketing Surveillance Strategies appeared first on ProRelix Research.

Marketing 98

Marketing Clinical Trials Trials Production 98

Drug Discovery World

FEBRUARY 6, 2024

As AI-designed drugs start to enter large-scale clinical trials, DDW’s Diana Spencer investigates how new digital tools are reinventing and reshaping drug discovery for the future. Quris-AI, which combines patient-on-a-chip, AI and real-time nano-sensing technologies to predict the safety and efficacy of drug candidates.

Marketing 174

Marketing Laboratories Engineering Clinical Trials 174

Drug Discovery World

AUGUST 14, 2023

While CGT is still an emerging market, its growth has accelerated over the last five years, resulting in a wave of products approved by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Driven by the rapid pace of innovation, the market for CGTs is expected to grow from $4.4

Marketing 130

Marketing DNA Therapies FDA 130

Drug Patent Watch

OCTOBER 2, 2023

The FDA conducted a study to identify factors that may predict the likelihood of generic drug marketing applications.

Marketing 111

Marketing FDA Drugs 111

Fierce BioTech

AUGUST 21, 2024

Market-Moving Trends to Watch in H2 2024 In a market defined by unpredictability, volatility, and fast-paced evolution, it can be challenging to determine where it’s heading and what executives should concern themselves with in the second half of 2024 and beyond. Interest in obesity drugs has led to billions of new prescriptions.

Marketing 52

Marketing Drugs 52

Common Sense for Drug Policy Blog

FEBRUARY 14, 2024

Nitazenes in the Global Drug Market "Highly potent synthetic opioids have not played such a prominent role in rising deaths among people who use drugs in the UK. Global drug markets are, however, rapidly evolving. Nitazenes-heralding a second wave for the UK drug-related death crisis? Lancet Public Health.

Marketing 52

Marketing Drugs Pharmaceuticals Production 52

BioPharma Drive: Drug Pricing

AUGUST 8, 2023

The Indianapolis drugmaker is now worth more than $500 billion, higher than any other pharmaceutical company, as analysts project lucrative markets for its obesity and Alzheimer's drugs.

Marketing 98

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 98

Collaborative Drug

APRIL 19, 2024

Tokyo, Japan, April 17, 2024 — In a significant move to bolster CDD Vault’s presence in the Japanese market, Collaborative Drug Discovery (CDD) is excited to announce the appointment of Mr. Yasushi Hamagashira as the new Head of Sales and Marketing for Japan.

Marketing 105

Marketing Drugs 105

Drug Discovery World

JULY 3, 2023

Emmanuel Abate, President of Genomic Medicine at Cytiva, said: “As pointed out in our 2023 Global Biopharma Resilience Index, collaborations are essential to solve the challenges of bringing future therapeutics to market.

Marketing 130

Marketing Therapies Virus Government 130

Drug Patent Watch

JULY 24, 2024

As patents expire on blockbuster biologic drugs, manufacturers are increasingly employing a controversial tactic known as “product hopping” to maintain […] Source

Production 98

Production Marketing Drugs 98

Drugs.com

JULY 19, 2024

Food and Drug Administration on Thursday authorized the sale of the country's best-selling e-cigarette.The agency's decision only applies to several tobacco-flavored versions of the reusable product, sold as Vuse. FRIDAY, July 19, 2024 -- The U.S.

Marketing 105

Marketing FDA Production Drugs 105

Drug Discovery World

NOVEMBER 8, 2022

The partnership means EIT Health will recommend PLG to early-stage b iotech start-ups requiring regulatory support to accelerate their journey to market. As well as providing funding, EIT Health’s VCoE aims to build start-ups market readiness, through valuable contacts and access to professional services. .

Marketing 130

Marketing Compliance Science Drugs 130

Drug Discovery World

FEBRUARY 21, 2023

Kristina Tatiossian , PhD, founder of Arkitekt Agency, looks at how biotech companies are currently using social media and provides a five-step guide for how to make the most of this ubiquitous marketing tool. Furthermore, marketing teams can tailor the organisation’s following to feature specific demographics.

Marketing 130

Marketing Science DNA Laboratories 130

Drug Discovery World

AUGUST 1, 2024

This is the latest episode of the free DDW narrated podcast, titled “Innovation drivers and opportunities for drug discovery”, which covers three articles written Volume 24 – Issue 1, Winter 2022/2023 of DDW. The post Podcast: Innovation drivers and opportunities for drug discovery appeared first on Drug Discovery World (DDW).

Drugs 130

Drugs Therapies Marketing Production 130

Drug Discovery World

SEPTEMBER 5, 2024

Biotechnology company SeaBeLife has secured orphan drug designation (ODD) from the European Medicines Agency (EMA) for its drug candidate SBL01 in the treatment of acute liver failure (ALF). In the EU, the population of patients with ALF is estimated to be between 1.3 in 10,000, meeting the EMA’s orphan designation threshold.

Small Molecule 148

Small Molecule Drugs Production Regulations 148

Common Sense for Drug Policy Blog

JUNE 6, 2024

Image and Performance Enhancing Drugs and Social Media Marketing "The final theme emanating from this exploration is the notable affordances and ‘malaffordances’ of both platforms that facilitate IPED supply. This has potentially negative consequences for the safety of users and the regulation of the market."

Marketing 40

Marketing Drugs Regulations 40